# Hyperspectral Drusen Classification

> **NCT06860555** · — · COMPLETED · sponsor: **Optina Diagnostics Inc.** · enrollment: 112 (actual)

## Conditions studied

- Dry Age Related Macular Degeneration

## Interventions

- **DEVICE:** Mydriatic Hyperspectral retinal Camera, (MHRC) and Optical coherence tomography (OCT)

## Key facts

- **NCT ID:** NCT06860555
- **Lead sponsor:** Optina Diagnostics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-08
- **Primary completion:** 2023-08-15
- **Final completion:** 2023-08-15
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06860555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06860555, "Hyperspectral Drusen Classification". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06860555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*